Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein-Coding Genetic Variant Related to Crohn's Disease

By Labmedica staff writers
Posted on 21 May 2008
A protein-coding genetic variation was identified that provides evidence for an abnormal immune response to bacteria in the digestive tract that may lead to the intestinal inflammation characteristic of Crohn's disease.

A team of scientists tested DNA samples from patients with Crohn's disease, comparing them with normal DNA samples. More...
The investigators conducted a genome-wide association scan of approximately 20,000 ‘coding' genetic variants that are thought to produce functional changes at the protein level. A novel genetic variant in a gene was identified and verified that had not been previously associated with Crohn's disease. The protein-coding genetic variation identified provides evidence that an abnormal immune response to bacteria in the digestive tract may lead to the intestinal inflammation characteristic of Crohn's disease.

The University Hospital of the Christian-Albrechts University (Kiel, Germany), together with Applied Biosystems (Foster City, CA, USA), developed the methods that led to the identification of the novel genetic variant. The collaboration led to the discovery of another piece of the genetic puzzle that may predispose humans to Crohn's disease, demonstrating a discovery pipeline that can be applied to other common disorders. Applied Biosystems single nucleotide polymorphisms (SNPs) genotyping system and other Applied Biosystems technologies including the AB 3730 genetic analyzer and TaqMan SNP genotyping assays were used for the study.

The editors of Bio-IT [Information Technology] World honored Applied Biosystems and Christian-Albrechts University with a Bio-IT World 2008 Best Practices Award for Basic Research R&D.

Bio-IT World's Best Practices Award program, which was established in 2003, recognizes teams for their novel and innovative use of technology to improve the efficiency and economics of R&D, drug discovery, clinical research, and trials. The award program is meant to bring broader awareness to the life science field's most innovative best practices and encourage the sharing of information among the scientific community.

The results of this collaboration were published in the February 2007 issue of the journal Nature Genetics. In addition, Bio-IT World plans to publish more information about this study.


Related Links:
Christian-Albrechts University
Applied Biosystems

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.